Lakefront Biotherapeutics is a biotechnology company bringing together world-class deal making expertise with capital to identify, acquire, and advance promising opportunities that drive value for patients and shareholders.​

We are listed on Euronext Amsterdam and Brussels and on NASDAQ, with ticker symbol LKFT. We have an international investor base, with a long term commitment to the biotech industry. Whether you are a current investor in Lakefront Biotherapeutics or are evaluating it as a potential investment opportunity, we welcome you to contact us if you have any additional questions after reviewing our website.